Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
about
Practice characteristics and prior authorization costs: secondary analysis of data collected by SALT-Net in 9 central New York primary care practices.National patterns of codeine prescriptions for children in the emergency department.Adoption of new drugs by physicians: a survival analysisEvaluating the impact of a novel restricted reimbursement policy for quinolone antibiotics: a time series analysisThe rise and fall of gabapentin for bipolar disorder: a case study on off-label pharmaceutical diffusion.Comparison of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors use in Australia and Nova Scotia (Canada)Codeine use among children in the United States: a nationally representative study from 1996 to 2013.Impacts on Emergency Department Visits from Personal Responsibility Provisions: Evidence from West Virginia's Medicaid Redesign.
P2860
Q30770681-7DB644E8-61B8-4510-A5B3-0D41287EE9DFQ33551778-972AADFC-5913-4BAA-B9C8-884D46673092Q34188463-7C8CFE75-F133-4E46-BF60-2EE6BD546AFBQ34398177-C369A020-7D28-47A0-BFDD-8480CA6BD978Q34617315-487ABDEF-D024-4003-8DDB-AA8F087E4683Q37321437-5289552C-F466-4C71-AD32-E63C9E21CFEEQ39251463-5DEF17A7-5B1A-493E-A523-B454B3CC562FQ40113012-7DCBEA91-553D-4D38-857D-634C43C481F4
P2860
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@ast
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@en
type
label
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@ast
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@en
prefLabel
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@ast
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@en
P2860
P1476
Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.
@en
P2093
Mark V Siracuse
Phillip J Vuchetich
P2860
P304
P356
10.1111/J.1475-6773.2007.00766.X
P433
P577
2008-02-01T00:00:00Z